Published in Oncogene on October 06, 2008
The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science (2010) 2.53
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer (2010) 2.51
MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) (2009) 2.49
TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene (2009) 2.33
MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res (2009) 2.03
Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect (2009) 1.98
miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet (2010) 1.97
miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis (2010) 1.89
MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One (2010) 1.89
miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell (2010) 1.76
MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov (2012) 1.75
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat Immunol (2011) 1.67
MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res (2009) 1.61
Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res (2008) 1.59
Retracted Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem (2009) 1.56
MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc Natl Acad Sci U S A (2010) 1.49
Minireview: epigenetic changes in ovarian cancer. Endocrinology (2009) 1.49
Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.48
Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One (2011) 1.48
MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem (2012) 1.43
Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci (2010) 1.38
The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm (2014) 1.33
Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol (2010) 1.33
Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell (2010) 1.31
MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum (2011) 1.31
Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) (2011) 1.30
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis (2009) 1.29
Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood (2009) 1.26
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer. Gynecol Oncol (2009) 1.26
MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med (2010) 1.25
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21
The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron (2010) 1.21
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene (2015) 1.16
MicroRNA-biogenesis and Pre-mRNA splicing crosstalk. J Biomed Biotechnol (2009) 1.15
MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer (2012) 1.13
The Role of MicroRNAs in Regulatory T Cells and in the Immune Response. Immune Netw (2011) 1.13
Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One (2012) 1.12
Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. Reprod Sci (2012) 1.11
Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells. Biochem J (2011) 1.09
MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int (2014) 1.07
CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells. Cancer Res (2011) 1.06
MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics. World J Gastroenterol (2012) 1.04
MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction. Diabetes (2013) 1.03
MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis. Oncotarget (2014) 1.02
MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1. Cancer Cell Int (2014) 1.01
microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer. Oncol Lett (2013) 1.01
High-throughput functional microRNAs profiling by recombinant AAV-based microRNA sensor arrays. PLoS One (2012) 1.01
Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness. Neuro Oncol (2014) 1.00
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res (2012) 1.00
MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma. J Exp Clin Cancer Res (2015) 0.99
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region. Nucleic Acids Res (2011) 0.99
MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1. PLoS One (2013) 0.98
Novel microRNAs in silkworm (Bombyx mori). Funct Integr Genomics (2010) 0.97
miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis. World J Gastroenterol (2013) 0.97
miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer. Mol Cancer (2013) 0.97
MicroRNAs and essential components of the microRNA processing machinery are not encoded in the genome of the ctenophore Mnemiopsis leidyi. BMC Genomics (2012) 0.96
Differential miRNA expression profiles between the first and third trimester human placentas. Am J Physiol Endocrinol Metab (2013) 0.95
Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects. World J Gastroenterol (2014) 0.95
Regulation of microRNA biogenesis and turnover by animals and their viruses. Cell Mol Life Sci (2013) 0.95
Targeting MYC-Regulated miRNAs to Combat Cancer. Genes Cancer (2010) 0.94
MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest (2015) 0.93
An analytical platform for mass spectrometry-based identification and chemical analysis of RNA in ribonucleoprotein complexes. Nucleic Acids Res (2009) 0.93
The intestinal microbiota interferes with the microRNA response upon oral Listeria infection. MBio (2013) 0.93
MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer. PLoS One (2015) 0.93
MicroRNAs - Biology and clinical applications. J Oral Maxillofac Pathol (2014) 0.93
Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy. Am J Transl Res (2013) 0.92
Genome-wide profiling of microRNAs in adipose mesenchymal stem cell differentiation and mouse models of obesity. PLoS One (2011) 0.92
Pulmonary microRNA profiling in a mouse model of ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2012) 0.92
miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol (2012) 0.91
Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms. Arterioscler Thromb Vasc Biol (2011) 0.90
Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol Carcinog (2013) 0.90
CPEB2, CPEB3 and CPEB4 are coordinately regulated by miRNAs recognizing conserved binding sites in paralog positions of their 3'-UTRs. Nucleic Acids Res (2010) 0.89
Inhibition of histone deacetylases in inflammatory bowel diseases. Mol Med (2011) 0.89
On the nature of in vivo requirements for rde-4 in RNAi and developmental pathways in C. elegans. RNA Biol (2011) 0.89
MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ. PLoS One (2013) 0.89
Involvement of MicroRNA in T-Cell Differentiation and Malignancy. Int J Hematol Oncol Stem Cell Res (2015) 0.88
Prioritizing human cancer microRNAs based on genes' functional consistency between microRNA and cancer. Nucleic Acids Res (2011) 0.88
miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis. PLoS One (2014) 0.88
MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML. J Cell Commun Signal (2011) 0.88
Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma. J Transl Med (2013) 0.88
Differentiation therapy of acute myeloid leukemia. Cancers (Basel) (2011) 0.87
SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genes. Nat Commun (2015) 0.87
Next-generation sequencing identifies deregulation of microRNAs involved in both innate and adaptive immune response in ALK+ ALCL. PLoS One (2015) 0.87
MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma. J Biol Chem (2015) 0.85
Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. Mol Cancer (2015) 0.84
MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer. Int J Clin Exp Pathol (2015) 0.84
High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells. World J Gastroenterol (2012) 0.84
MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol (2013) 0.84
Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2. Cancer Immunol Res (2014) 0.84
Amplified microRNA detection by templated chemistry. Nucleic Acids Res (2012) 0.83
Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest. PLoS One (2014) 0.83
Identification of miRNAs in a liver of a human fetus by a modified method. PLoS One (2009) 0.83
Genome-wide search for miRNA-target interactions in Arabidopsis thaliana with an integrated approach. BMC Genomics (2012) 0.83
Upregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells. J Cancer (2015) 0.83
Identification and analysis of differentially-expressed microRNAs in Japanese encephalitis virus-infected PK-15 cells with deep sequencing. Int J Mol Sci (2015) 0.83
Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways. Biomed Res Int (2014) 0.82
Identification of miRNAs Expression Profile in Gastric Cancer Using Self-Organizing Maps (SOM). Bioinformation (2014) 0.82
Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer. Med Sci Monit (2015) 0.82
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Two CD95 (APO-1/Fas) signaling pathways. EMBO J (1998) 10.42
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (1997) 6.23
FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J (1997) 4.56
FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem (1996) 3.72
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem (1999) 3.32
Apoptosis signaling by death receptors. Eur J Biochem (1998) 3.06
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ (2005) 2.91
Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem (1999) 2.52
Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res (1997) 2.32
FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem (1997) 2.29
Differences between CD95 type I and II cells detected with the CD95 ligand. Cell Death Differ (1999) 1.99
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U S A (1999) 1.56
Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J Immunol (2000) 1.43
Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem (1998) 1.41
Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol Cell Biol (2000) 1.40
CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene (1996) 1.33
Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J Biol Chem (1998) 1.32
Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur J Immunol (1997) 1.29
Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood (2000) 1.25
The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm. J Biol Chem (2001) 1.18
Apoptosis signaling in lymphocytes. Curr Opin Immunol (1999) 1.16
DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J (1998) 1.12
Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet (2008) 1.10
Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. J Immunol (1999) 1.05
Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy (2008) 1.04
Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy (2010) 1.04
Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription. Cell Death Differ (2001) 1.03
Mapping small GTP-binding proteins on high-resolution two-dimensional gels by a combination of GTP binding and labeling with in situ periodate-oxidized GTP. Electrophoresis (1994) 1.01
Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology (1999) 1.00
Phosphatidylinositol 3'-kinase blocks CD95 aggregation and caspase-8 cleavage at the death-inducing signaling complex by modulating lateral diffusion of CD95. J Immunol (2001) 0.99
ICE-proteases mediate HTLV-I Tax-induced apoptotic T-cell death. Oncogene (1997) 0.99
Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short). Cancer Res (2001) 0.97
Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. Methods (1999) 0.96
APO-1(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett (1995) 0.94
Inhibitory effects of quercetin on aflatoxin B1-induced hepatic damage in mice. Food Chem Toxicol (2010) 0.92
The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects. J Clin Endocrinol Metab (2013) 0.92
Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells. Cell Death Differ (1998) 0.90
Ternary mixed monolayers for simultaneous DNA orientation control and surface passivation for label free DNA hybridization electrochemical sensing. Biosens Bioelectron (2010) 0.88
S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis. Int Immunol (1996) 0.88
The TRAIL DISCussion: It is FADD and caspase-8! Cell Death Differ (2000) 0.84
Apoptosis and caspases. Cardiol Clin (2001) 0.84
Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds. Clin Genet (2011) 0.83
Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Blood (1998) 0.83
Benign gastroenteric fistula and aspirin abuse. Arch Surg (1972) 0.82
The role of CD95 and CD95 ligand in cancer. Cell Death Differ (2015) 0.81
Does the Caenorhabditis elegans protein CED-4 contain a region of homology to the mammalian death effector domain? Cell Death Differ (1997) 0.81
Fusing DEDD with ubiquitin changes its intracellular localization and apoptotic potential. Apoptosis (2005) 0.81
Transplanted islets from lpr mice are resistant to autoimmune destruction in a model of streptozotocin-induced type I diabetes. Apoptosis (2005) 0.80
Serial observations on immunologically matched lung allografts. J Thorac Cardiovasc Surg (1972) 0.80
Analysis of the CD95 (APO-1/Fas) death-inducing signaling complex by high-resolution two-dimensional gel electrophoresis. Methods Enzymol (2000) 0.79
Coupling of GTP-binding to the T cell receptor (TCR) zeta-chain with TCR-mediated signal transduction. J Immunol (1993) 0.79
Fabrication of a biodegradable xenoantigen-free rat liver scaffold for potential drug screening applications. Transplant Proc (2013) 0.78
Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring. Diabet Med (2014) 0.78
Acute rejection after swine leukocyte antigen-matched kidney allo-transplantation in cloned miniature pigs with different mitochondrial DNA-encoded minor histocompatibility antigen. Transplant Proc (2013) 0.77
Taming TRAIL: the winding path to a novel form of cancer therapy. Cell Death Differ (2005) 0.77
Tuberculous enteritis. West J Med (1976) 0.77
CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8. Cell Death Differ (2005) 0.76
Effect and mechanism of lipopolysaccharide on allergen-induced interleukin-5 and eotaxins production by whole blood cultures of atopic asthmatics. Clin Exp Immunol (2007) 0.75
Disparate hypervariable region-1 of mitochondrial DNA did not induce skin allograft rejection in cloned porcine models. Transplant Proc (2013) 0.75
Characterization of the GTP/GDP binding site in the murine CD3-zeta polypeptide chain. Immunol Lett (1994) 0.75
Mouse adipose tissue-derived adult stem cells expressed osteogenic specific transcripts of osteocalcin and parathyroid hormone receptor during osteogenesis. Transplant Proc (2013) 0.75
Educational Corner: Activation-induced T cell death. Cell Death Differ (1996) 0.75
Clinical use of procine xenografts in conditions other than burns. Surg Gynecol Obstet (1974) 0.75
Technical notes on lung transplantation with donor survival in inbred beagles. Transplantation (1972) 0.75